145 related articles for article (PubMed ID: 3191338)
1. Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate.
Ritchie AW; Dorey F; Layfield LJ; Hannah J; Lovrekovich H; deKernion JB
Br J Urol; 1988 Sep; 62(3):245-60. PubMed ID: 3191338
[TBL] [Abstract][Full Text] [Related]
2. DNA-ploidy as prognostic factor in prostatic carcinoma.
Haugen OA; Mjølnerød O
Int J Cancer; 1990 Feb; 45(2):224-8. PubMed ID: 2303288
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
[TBL] [Abstract][Full Text] [Related]
4. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.
Lee SE; Currin SM; Paulson DF; Walther PJ
J Urol; 1988 Oct; 140(4):769-74. PubMed ID: 3047437
[TBL] [Abstract][Full Text] [Related]
6. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry.
Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904
[TBL] [Abstract][Full Text] [Related]
7. Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer.
Pollack A; Zagars GK; el-Naggar AK; Terry NH
Urology; 1994 Nov; 44(5):711-8. PubMed ID: 7526527
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA analysis of advanced prostatic adenocarcinoma.
Wu WJ; Huang MS; Wang HJ; Chiang PH; Huang CH; Chiang CP
Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Mar; 9(3):122-30. PubMed ID: 8510195
[TBL] [Abstract][Full Text] [Related]
9. Pathologic parameters and flow cytometric ploidy analysis in predicting recurrence in carcinoma of the prostate.
Voges GE; Eigner EB; Ross W; Sussman H; Stöckle M; Freiha FS; Stamey TA
Eur Urol; 1993; 24(1):132-9. PubMed ID: 8365433
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy.
Gauwitz MD; Pollack A; el-Naggar AK; Terry NH; von Eschenbach AC; Zagars GK
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):821-8. PubMed ID: 8138434
[TBL] [Abstract][Full Text] [Related]
11. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of DNA ploidy in carcinoma of prostate.
Dejter SW; Cunningham RE; Noguchi PD; Jones RV; Moul JW; McLeod DG; Lynch JH
Urology; 1989 May; 33(5):361-6. PubMed ID: 2711553
[TBL] [Abstract][Full Text] [Related]
13. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
[TBL] [Abstract][Full Text] [Related]
14. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer.
Frankfurt OS; Chin JL; Englander LS; Greco WR; Pontes JE; Rustum YM
Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384
[TBL] [Abstract][Full Text] [Related]
15. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
16. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
[TBL] [Abstract][Full Text] [Related]
17. Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometry.
Berner A; Danielsen HE; Juul NO; Juul ME; Pettersen EO; Reith A; Nesland JM; Fosså SD
Anal Cell Pathol; 1993 Nov; 5(6):339-52. PubMed ID: 8305330
[TBL] [Abstract][Full Text] [Related]
18. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease.
Carmichael MJ; Veltri RW; Partin AW; Miller MC; Walsh PC; Epstein JI
J Urol; 1995 Mar; 153(3 Pt 2):1015-9. PubMed ID: 7853549
[TBL] [Abstract][Full Text] [Related]
19. Significance of abnormal diploid DNA histograms in localized prostate cancer and adjacent benign prostatic tissue.
Deitch AD; Miller GJ; deVere White RW
Cancer; 1993 Sep; 72(5):1692-700. PubMed ID: 7688657
[TBL] [Abstract][Full Text] [Related]
20. Large scale genomic instability as an additive prognostic marker in early prostate cancer.
Pretorius ME; Waehre H; Abeler VM; Davidson B; Vlatkovic L; Lothe RA; Giercksky KE; Danielsen HE
Cell Oncol; 2009; 31(4):251-9. PubMed ID: 19633362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]